Tonix Pharmaceuticals Holding Corp. Releases Preliminary Year-End 2024 Financial Results

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) recently published selected preliminary operating results and financial condition information for the year ending December 31, 2024. The company disclosed that it held approximately $98.8 million in cash and cash equivalents as of December 31, 2024, which is anticipated to sustain planned operations well into the first quarter of […]

Leave a Reply

Your email address will not be published.

Previous post Trifecta Gold (CVE:TG) Stock Price Up 35.4% – Still a Buy?
Next post Nov. 6, 1969: Herald reports